Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1992-10-19
1993-09-14
Schain, Howard E.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
530331, A61K 3724, A61K 3743
Patent
active
052448843
ABSTRACT:
There are disclosed thionated analogues of thyrotropin releasing hormone, having the formula: ##STR1## wherein, Q, W, X and Y, same or different, are oxygen or sulfur, with the proviso that at least one of Q, W, X and Y is always sulfur;
REFERENCES:
patent: 4215110 (1980-07-01), Lotti et al.
patent: 4426378 (1984-01-01), Holaday
patent: 4608365 (1986-08-01), Engel
L. Lankiewicz, Abstract Form, 11th Am. Peptide Symposium, Jul. 1989 The Salk Institute, Univ. of Calif., San Diego.
Jean E. Rivier and Garland R. Marshall "Peptides", Chemistry, Structure and Biology, Proceedings of the 11th American Peptide Symposium, Jul. 1989, Calif.
Marian Kruscynski, Polish Journal of Chemistry "Synthesis of a TRH Analog with a C-Terminal Thioamide Group", 60, 95 (1986).
Experientia 41, (1985), M. Kruszynski et al.; "TRH analogue with C-terminal thioamide group."
The New England Journal of Medicine, Jul. 24, 1980, pp. 224-225.
Neurology 36, Sep. 1986, pp. 1218-1221.
Acta Physiol Scand, 1979, 106:83-86, F. Koivusalo et al., "The Effect of Centrally Administered TRH on Blood Pressure, Heart Rate and Ventilation in Rat".
Neuroendocrinology 35:173-177 (1982); Bao L. Tsay et al.; "Effects of Intracerebroventricular Administration of Thyrotrophic-Releasing Hormone on Cardiovascular Function in the Rat".
Brain Research Bulletin, vol. 6, pp. 13-17, J. P. Farber et al.; "Effects on Breathing of Putative Neurotransmitters in the Rostral Hypothalamus of the Rat".
Progress in Neurobiology, vol. 12, pp. 291-312 (1979), G. Yarbrough.
Neuropeptides, vol. 8, pp. 63-70; (1986); A. L. Siren et al.
Stefan Vonhof et al., European Journal of Pharmacology, vol. 164, pp. 77-83, (1989).
Geoffrey Metcalf et al., Elsevier Biomedical Press, 3, pp. 193-206, (1982).
Ruth F. Nutt et al., J. Med. Chem., vol. 24, pp. 692-698, (1981).
D. Brewster et al., Neuropeptides, vol. 1, pp. 153-165, (1981).
K. Funatsu et al., Peptides, vol. 6, pp. 563-566 (1985).
E. F. Hawkins et al.; Life Sciences, vol. 36, pp. 601-611 (Pergamon Press).
N. Ogawa et al., Peptides, vol. 3, pp. 669-677 (1982).
Geoffrey Metcalf et al., Regulatory Peptides, vol. 2, pp. 277-284 (1981).
N. A. Sharif, TIPS-Mar. 1985, pp. 119-122.
T. McIntosh, et al., Am. J. Physiol., vol. 254, pp. R785-R792.
F. Brambilla et al., Neuropsychobiology, vol. 15, pp. 114-121 (1986).
John N. Whitaker et al., Annals of Nuerology, vol. 22, No. 4 (1987).
H. N. Bhargava, Psychopharmacology, vol. 68, pp. 185-189 (1980).
The Lancet, Jan. 27, 1979, pp. 210-211.
The Lancet, Feb. 23, 1980 pp. 424-425.
L. Koskinen, Annals N.Y. Academy of Sciences, 1989, Section VIII, pp. 353-387.
T. Munsat et al.; Annals of N.Y. Acad. of Sciences, pp. 388-475.
Labroo Virender M.
Lankiewicz Leszek
Spatola Arno F.
Vonhof Stefan
Schain Howard E.
The United States of America as represented by the Department of
LandOfFree
Thionated analogues of thyrotropin releasing hormone does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Thionated analogues of thyrotropin releasing hormone, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Thionated analogues of thyrotropin releasing hormone will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2026620